Hambardzumyan, Karen <br/><br/>
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jun 2015 
 - 1102-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2013-204986  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipokines--metabolism<br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--diagnostic imaging<br/>Biomarkers--metabolism<br/>C-Reactive Protein--metabolism<br/>Chitinase-3-Like Protein 1<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Epidermal Growth Factor--metabolism<br/>Female<br/>Foot Joints--diagnostic imaging<br/>Hand Joints--diagnostic imaging<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Infliximab<br/>Interleukin-6--metabolism<br/>Lectins--metabolism<br/>Leptin--metabolism<br/>Logistic Models<br/>Male<br/>Matrix Metalloproteinase 1--metabolism<br/>Matrix Metalloproteinase 3--metabolism<br/>Methotrexate--therapeutic use<br/>Multivariate Analysis<br/>Prognosis<br/>Radiography<br/>Receptors, Tumor Necrosis Factor, Type I--metabolism<br/>Resistin--metabolism<br/>Serum Amyloid A Protein--metabolism<br/>Severity of Illness Index<br/>Sulfasalazine--therapeutic use<br/>Treatment Outcome<br/>Vascular Cell Adhesion Molecule-1--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism